Pediatrix Medical Group Inc (NYSE: MD) established initial surge of 4.69% at $16.08, before settling in for the price of $15.36 at the close. Taking a more long-term approach, MD posted a 52-week range of $6.62-$15.52.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded -7.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 7.25%. This publicly-traded company’s shares outstanding now amounts to $85.88 million, simultaneously with a float of $84.56 million. The organization now has a market capitalization sitting at $1.38 billion. At the time of writing, stock’s 50-day Moving Average stood at $11.89, while the 200-day Moving Average is $9.47.
Pediatrix Medical Group Inc (MD) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Pediatrix Medical Group Inc industry. Pediatrix Medical Group Inc’s current insider ownership accounts for 1.54%, in contrast to 101.84% institutional ownership. Preceding that transaction, on Aug 30 ’24, Company’s Chief Executive Officer sold 11,100 for 10.79, making the whole transaction’s value amount to 119,769. This particular insider is now the holder of 170,001 in total.
Pediatrix Medical Group Inc (MD) Earnings and Revenue Records
Pediatrix Medical Group Inc’s EPS increase for this current 12-month fiscal period is 7.25% and is forecasted to reach 1.53 in the upcoming year.
Pediatrix Medical Group Inc (NYSE: MD) Trading Performance Indicators
Let’s observe the current performance indicators for Pediatrix Medical Group Inc (MD). It’s Quick Ratio in the last reported quarter now stands at 1.42. The Stock has managed to achieve an average true range (ATR) of 0.61. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.69. Similarly, its price to free cash flow for trailing twelve months is now 11.99.
In the same vein, MD’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -3.06, a figure that is expected to reach 0.37 in the next quarter, and analysts are predicting that it will be 1.53 at the market close of one year from today.
Technical Analysis of Pediatrix Medical Group Inc (MD)
Now, what If we examine the latest scores posted by [Pediatrix Medical Group Inc, MD]. During the last 5-days, its volume was better the volume of 0.87 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 92.66% While, its Average True Range was 0.70.
Raw Stochastic average of Pediatrix Medical Group Inc (MD) in the period of the previous 100 days is set at 96.63%, which indicates a major rise in contrast to 91.99% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 90.85% that was higher than 59.02% volatility it exhibited in the past 100-days period.
